Evidence map›Paper›PMID 37093838›Full record

ArticlePigment cell & melanoma research2023

Diversity, equity, and inclusion in the melanoma research community.

Marie E Portuallo, David Y Lu, Gretchen M Alicea, Joel Bolling, Rebecca Lee, Jennifer McQuade, Allison Betof Warner, Michael Davies, Ashani Weeraratna, Jessie Villanueva and 1 more

Open access · hybridAbstract readLetter
In one paragraph

Article in Pigment cell & melanoma research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Marie E PortualloJohns Hopkins University, Baltimore, Maryland, USA.
David Y LuCornell University, Ithaca, New York, USA.
Gretchen M AliceaJohns Hopkins University, Baltimore, Maryland, USA.
Joel BollingJohns Hopkins University, Baltimore, Maryland, USA.
Rebecca LeeUniversity of Manchester, Manchester, UK.
Jennifer McQuadeMD Anderson Cancer Center, Houston, Texas, USA.
Allison Betof WarnerMemorial Sloan Kettering Cancer Center, New York, New York, USA.
Michael DaviesMD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-5196-6919
Ashani WeeraratnaJohns Hopkins University, Baltimore, Maryland, USA.
Jessie VillanuevaThe Wistar Institute, Philadelphia, Pennsylvania, USA.
Vito W RebeccaJohns Hopkins University, Baltimore, Maryland, USA.
Johns Hopkins University · USThe University of Texas MD Anderson Cancer Center · USCornell University · USMemorial Sloan Kettering Cancer Center · USThe Wistar Institute · USUniversity of Manchester · GB

Funding

Tumor Microenvironment and MetastasisP30CA010815 · NCI · WISTAR INSTITUTE · PI Aaron Robert Goldman · 1985 to 2026
$75.9M
Dissecting clonal diversity in melanoma to overcome therapy resistance andmetastasisK01CA245124 · NCI · JOHNS HOPKINS UNIVERSITY · PI REBECCA, VITO WILLIAM · 2020 to 2024
$595k
NCI NIH HHS K01 CA245124NCI NIH HHS P30 CA010815Wellcome Trust 225724
6 · The paper itself

Abstract

The inaugural Diversity and Inclusion in Science Session was held during the 2021 Society for Melanoma Research (SMR) congress. The goal of the session was to discuss diversity, equity, and inclusion in the melanoma research community and strategies to promote the advancement of underrepresented melanoma researchers. An international survey was conducted to assess the diversity, equity, and inclusion (DEI) climate among researchers and clinicians within the Society for Melanoma Research (SMR). The findings suggest there are feelings and experiences of inequity, bias, and harassment within the melanoma community that correlate with one's gender, ethnic/racial group, and/or geographic location. Notably, significant reports of inequity in opportunity, discrimination, and sexual harassment demonstrate there is much work remaining to ensure all scientists in our community experience an academic workplace culture built on mutual respect, fair access, inclusion, and equitable opportunity.

Indexed as

Diversity, Equity, InclusionMelanomaHumansdiversityequityinclusionmelanoma

Identifiers

PMID37093838
PMCPMC10896642
OpenAlexW4366821916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.